University of Illinois at Chicago
Exemption #JDR535
Announcement of an Exempt Purchase
Award Info Published Thursday August 21, 2025
ASD Specialty Healthcare LLC/ASD HealthcareFrisco, TX
- Amount: An estimated $1,800,000
- Terms: An estimated start date of 8/18/2025 through 6/30/2028
- Renewals: None
Summary
Vendors
1 total
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed as this award goes through a state approval process.
First published Thursday, August 21, 2025
The University awarded a contract for Welireg, a restricted prescription medication.
This exemption is for Welireg, a restricted prescription medication used for several types of cancer.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical at a university-operated health care center or dispensary that provides care, treatment, and medications for students, faculty and staff (30 ILCS 500 / 1-13(b-5)) Welireg has been proven to reduce the risk of advanced cancer from growing, spreading, or getting worse. In some cancers, this medication has been proven to shrink tumors. Without access to this medication, the pharmacy would not be able to deliver proper care to UI Health patients, which would drive patients elsewhere and result in a loss of revenue to UI Health.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.